Open Access Open Access  Restricted Access Subscription or Fee Access

Update on Epidemiology, Virion Structure, Pathogenesis, Diagnosis, Treatment of COVID-19 with Future Perspectives: A Narrative Review

Madhusmita Nayak, Debajani Nayak

Abstract


COVID-19 or coronavirus disease 2019 is a pandemic contagion, leading to the death of many more people globally. In simpler terms, COVID-19 is a very contagious illness caused by the SARS-CoV-2 virus, which stands for severe acute respiratory syndrome coronavirus-2. The main aim of the present paper was to give an update about the incidence, mode of spread, viral multiplication, treatments available, complications with future expectations. The virus's ability to spread is rapidly intensifying every day on a global scale. It has become a healthcare concern above all other comorbidities. One of the possible causes of such rapid spread is the inadequacy of the assessment of risk regarding the situational urgency. Its spread crossed the incidence of Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. Only one way can defeat the virus that is slowing the spread through social distancing, personal protection, and self-awareness. As a result, the burden on healthcare providers is ultimately lessened.. Therefore this coronavirus disease draws immediate attention for the therapeutic management of the virus. Thus the present paper reviewed the literature of all available information on the history, epidemiology, virion structure, its replication, sign and symptoms, antivirals available, and its future perspectives with a special note on myth, fact and management during pregnancy.

Keywords


COVID-19, epidemiology, virion structure, history, future perspectives, Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, pregnancy and COVID-19

Full Text:

PDF

References


Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Ganesan S, Venugopal A, Venkatesan D, Ganesan H, Rajagopalan K. COVID-19: A promising cure for the global panic. Science of the Total Environment. 2020; 4: 138277.

World Health Organization. 2019 Novel Coronavirus [Internet]. Geneva: WHO; 2023. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus2019?adgroupsurvey= {adgroupsurvey}&gclid=CjwKCAjw5MOlBhBTEiwAAJ8e1nwosD0rVcuuyPkldbGX3pjwOXW XURNmDIoHNgDHa5qF2usFVtRd_RoCt88QAvD_BwE [cited on 2023 Jul 14].

Dawood AA. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future. New Microbes and New Infections. 2020; 35: 100673. Available from: https://doi.org/10.1016/j.nmni. 2020.100673, PMID: 32292587 4.

Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Jul 2020; 24(1): 422. Available from: https://doi.org/10.1186/s13054-020- 03120-0.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research. 2020; 7(1): 11p. Available from: https://doi.org/10.1186/s40779-020-00240-0, PMID: 32169119

World Health Organization. Novel Coronavirus (2019-nCoV), Situation Report 1. Geneva: WHO; 2020 Jan 21. Available from: https://www.who.int/docs/default-source/coronaviruse/situation- reports/20200121-sitrep-1-2019-ncov.pdf (accessed on 21 April 2020).

Coronavirus in India: Latest Map and Case Count. Covid19india.org [Internet]; 2023. Available from: https://www.covid19india.org/ [cited 2023 Jul 14]

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhao Y. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94; 91–95p. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/32173574

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. (2020). Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 2020; 109(5): 531–538p. Available from: https://doi.org/10.1007/s00392-020-01626-9, PMID: 32161990

Who.int. (2023). Tracking SARS-CoV-2 variants [Online] Available from: https://www.who.int/ activities/tracking-SARS-CoV-2-variants.

Statista. Number of coronavirus (COVID-19) cases worldwide as of May 2, 2023, by country or territory. Available from https://www.statista.com/statistics/1043366/novel-coronavirus- 2019ncov-cases-worldwide-by-country/

Tian D, Sun Y, Xu H, Ye Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J Med Virol. 2022 Jun;94(6):2376-2383. doi: 10.1002/jmv.27643. Epub 2022 Feb 11. PMID: 35118687; PMCID: PMC9015498.

Dhar Chowdhury S, Oommen AM. Epidemiology of COVID-19. Journal of Digestive Endoscopy. 2020 Mar;11(1):3–7. doi: 10.1055/s-0040-1712187. PMCID: PMC7364648.

Fang L. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology. 2016; 3: 237–226p. Available from: https://www.annualreviews.org/doi/10.1146/ annurev-virology-110615-042301

Kahn JP, McIntosh K. History and Recent Advances in Coronavirus Discovery. Pediatre Infect Dis J. 2005; 24(11): S223–S227. Available from: https://pubmed.ncbi.nlm.nih.gov/16378050/ [cited on 2023 Jul 14].

Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q. Coronavirus infections and immune responses. Journal of medical virology. 2020 Apr;92(4):424-32.

ICTV. Ictv.global [Internet]; 2022. Available from: https://ictv.global/ [cited on 2023 Jul 14].

Strange W. COVID-19/SARS-CoV-2 Pandemic. FPM [Internet]; 2020. Available from: https://www.fpm.org.uk/blog/covid-19-sars-cov-2-pandemic/ [cited on 2023 Jul 14].

Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N, Bruzzone R. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. Journal of Virology. 2008; 82(22): 11318–11330p.

Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Hou C, Wang H, Liu J, Yang D, Xu Y. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care. 2020; 24(1): 422p.

Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Journal of Virology. 2005; 79(23): 14614–14621p.

Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systemic Infection. Clin Microbiol Rev. Jan 2021; 34(2):e00133-20. doi: 10.1128/CMR.00133-20.

Gupta, A., Madhavan, M.V., Sehgal, K. et al. Extrapulmonary manifestations of COVID-19. Nat Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3

Centers for Disease Control and Prevention. Symptoms of COVID-19. USA: CDC [Internet]; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html [cited 2023 Jul 14]

World Health Organization. Q&A Detail. Geneva: WHO; 2023. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q- a-detail/coronavirus-disease-covid-19#:~:text=symptoms [cited on 2023 Jul 14].

Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239–1242p. doi:10.1001/jama.2020.2648

Centersfor Disease Control & Prevention. Coronavirus Disease 2019 (COVID-19). Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). USA: CDC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases (NCIRD); 2023 Jan 27. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical- guidance-management-patients.html

Centers for Disease Control and Prevention. Interim Guidance: Healthcare Professionals 2019- nCoV. USA: CDC; 2020. Available from: https://www.cdc.gov/coronavirus/2019- nCoV/hcp/clinical-criteria.html

National Center for Disease Control. Guidelines on Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel coronavirus (nCoV) cases. New Delhi: NCDC; 2022. Available from: https://ncdc.gov.in/WriteReadData/l892s/96997299691580715786.pdf

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). InStatpearls [Internet]; 2020 Mar 8. PMID: 32150360.

Sahu KK, Mishra AK, Lal A. COVID-2019: update on epidemiology, disease spread and management. Monaldi Archives for Chest Disease. 2020; 90(1).

Simsek YS, Unal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020; 50(SI-1): 611–619p. doi: 10.3906/sag-2004-145. PMID:32293834

Guastalegname M, Vallone A. Could chloroquine/hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? Clinical Infectious Diseases. 2020; 71(15): 888–889p. PMID: 32211771.

Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends. 2020; 14(1): 72–73p.

Zhang R, Wang X, Ni L, Di X, Ma B, Niu S, Liu C, Reiter RJ. COVID-19: Melatonin as a potential adjuvant treatment. Life Sciences. 2020; 250: 117583. PMID: 32217117

National Institute for Research in Reproductive Health. Guidance for Management of Pregnant Women in COVID-19 Pandemic. New Delhi: ICMR; 2020. 1–17p. Available from: https://www.icmr.gov.in/pdf/covid/techdoc/Guidance_for_Management_of_Pregnant_Women_in _COVID19_Pandemic_12042020.pdf

Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, Zheng C. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. American Journal of Roentgenology. 2020; 215(1): 1–6p. PMID: 32186894

Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Archives of Pathology & Laboratory Medicine. 2020; 144(7): 799ؘ–805p. PMID: 32180426

Zhang L, Jiang Y, Wei M, Cheng BH, Zhou XC, Li J, Tian JH, Dong L, Hu RH. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province. Zhonghua fu chan ke za zhi. 2020; 55: E009. PMID: 32145714

Chowdhury SR, Chakrabarty S, Chakraborti M, Das A. Impacts of viral pathogenesis and vaccine immunization on the host humoral immune response in SARS-CoV-2 and associated variants of concern (VOCs) infection. InViral, Parasitic, Bacterial, and Fungal Infections 2023 Jan 1 (pp. 237- 262). Academic Press.

World Health Organization. COVID-19 Mythbusters. Geneva: WHO; 2023. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth- busters [cited on 2023 Jul 14]

Sharma D. Summer Temperatures Could Prevent Spread of COVID-19 in India Post Lockdown: Experts. The Weather Channel [Internet]; 2020. Available from: https://weather.com/en- IN/india/coronavirus/news/2020-03-26-summer-temperatures-prevent-spread-covid19-india-post- lockdown [cited on 2023 Jul 14].

Payne M. Fact check: To minimize coronavirus risk, use alcohol for sanitizing, not for drinking. USA TODAY, Fort Myers News-Press [Internet].; 2020. Available from: https://www.usatoday.com/story/news/factcheck/2020/03/20/fact-check-drinking-alcohol-wont-reduce-coronavirus- risk/2881704001/ [cited on 2023 Jul 14].

Tijani M. Experts say eating garlic does not prevent COVID-19 -- and onions are no cure either. AFP Factcheck [Internet]; 2020 Mar 27. Available from: https://factcheck.afp.com/experts-say- eating-garlic-does-not-prevent-covid-19-and-onions-are-no-cure-either

Di Gennaro F, Pizzol D, Marotta C, Antunes M, Racalbuto V, Veronese N, Smith L. Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review. International Journal of Environmental Research and Public Health. 2020; 17(8): 2690p.

Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspective. International Journal of Antimicrobial Agents. 2020; 55(5): 105951.

Samavati L, Uhal BD. ACE2, Much More Than Just a Receptor for SARS-COV-2. Frontiers in Cellular and Infection Microbiology. 2020 Jun 5;10:317.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Research & Reviews: A Journal of Immunology

This Journal archive has been shifted to: https://journals.stmjournals.com/archive/rrjoi/